In addition, increased concentrations of β-hydroxybutyrate were able to directly ameliorate the energy deficit in several different pathological conditions: hypoglycemia, GLUT1 transporter deficiency, and pyruvate dehydrogenase complex deficiency. This evidence concerns the gene SLC2A1 and Hypoglycemia.